These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 497377)

  • 1. [Effect of beta-phenylethylamine on evoked potentials of the neostriatum of rats].
    Zharikova AD; Godukhin OV
    Biull Eksp Biol Med; 1979 Oct; 88(10):395-8. PubMed ID: 497377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Presynaptic regulation of dopamine release by beta-phenylethylamine].
    Zharikova AD; Godukhin OV
    Biull Eksp Biol Med; 1984 Nov; 98(11):574-6. PubMed ID: 6095945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Presynaptic autoregulation of dopamine release].
    Zharikova AD; Godukhin OV
    Fiziol Zh SSSR Im I M Sechenova; 1985 Jan; 71(1):105-12. PubMed ID: 2982672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of beta-phenylethylamine on the dopaminergic system of rat brain].
    Zharikov SI; Zharikova AD; Budantsev AIu
    Neirofiziologiia; 1979; 11(6):578-84. PubMed ID: 514416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evoked potentials in the rat neostriatum during local cooling of the cortex in the zone of primary response to the applied stimulus].
    Tolkunov BF; Golubev AV
    Zh Evol Biokhim Fiziol; 1988; 24(3):350-6. PubMed ID: 3176770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral supersensitivity to beta-phenylethylamine after chronic administration of haloperidol.
    Stoff DM; Jeste DV; Gillin JC; Moja EA; Cohen L; Stauderman KA; Wyatt RJ
    Biol Psychiatry; 1984 Jan; 19(1):101-6. PubMed ID: 6538440
    [No Abstract]   [Full Text] [Related]  

  • 9. [The striatonigral dopaminergic system and its role in adaptive conditioned reflex behavior].
    Suvorov NF; Iakimovskiĭ AF; Saul'skaia NB
    Fiziol Zh SSSR Im I M Sechenova; 1984 May; 70(5):594-600. PubMed ID: 6468694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Excitation and inhibition processes in the neurons of the thalamic motor nuclei of normal cats and following an N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced lesion of the nigrostriatal dopaminergic system].
    Voloshin MIa; Lukhanina EP; Kolomiets BP; Burchinskaia LF; Nosenko ND
    Neirofiziologiia; 1989; 21(5):620-9. PubMed ID: 2557553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. R-(-)-deprenyl (Selegiline, Movergan) facilitates the activity of the nigrostriatal dopaminergic neuron.
    Knoll J
    J Neural Transm Suppl; 1987; 25():45-66. PubMed ID: 2828537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of presynaptic dopamine receptors in regulation of the glutamatergic neurotransmission in rat neostriatum.
    Godukhin OV; Zharikova AD; Budantsev AYu
    Neuroscience; 1984 Jun; 12(2):377-83. PubMed ID: 6146947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of beta-phenylethylamine on extracellular concentrations of dopamine in the nucleus accumbens and prefrontal cortex.
    Murata M; Katagiri N; Ishida K; Abe K; Ishikawa M; Utsunomiya I; Hoshi K; Miyamoto K; Taguchi K
    Brain Res; 2009 May; 1269():40-6. PubMed ID: 19285043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic regulation of tachykinin metabolism in the striatonigral pathway.
    Li SJ; Sivam SP; McGinty JF; Huang YS; Hong JS
    J Pharmacol Exp Ther; 1987 Nov; 243(2):792-8. PubMed ID: 2445959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of NMDA and MK-801 injected into the substantia nigra pars reticulata on jaw movements evoked by dopamine D1-/D2 receptor stimulation in the ventrolateral striatum: studies in freely moving rats.
    Uchida T; Lee J; Fujita S; Kiguchi M; Matsumoto M; Oi Y; Gionhaku N; Koshikawa N
    Methods Find Exp Clin Pharmacol; 2005; 27(1):31-7. PubMed ID: 15834457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoreceptor-mediated changes in dopaminergic terminal excitability: effects of striatal drug infusions.
    Tepper JM; Nakamura S; Young SJ; Groves PM
    Brain Res; 1984 Sep; 309(2):317-33. PubMed ID: 6089960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurotensin-induced dopamine release in vivo and in vitro from substantia nigra and nucleus caudate.
    Faggin BM; Zubieta JK; Rezvani AH; Cubeddu LX
    J Pharmacol Exp Ther; 1990 Feb; 252(2):817-25. PubMed ID: 2138224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of damage of the nigro-neostriatal dopaminergic system by MPTP on the transmission of corticofugal impulses to the neurons of the caudate nucleus].
    Oleshko NN
    Fiziol Zh (1978); 1989; 35(6):33-9. PubMed ID: 2558913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacological modification of evoked caudate nucleus potentials].
    Lehmann K; Andreas K
    Acta Biol Med Ger; 1979; 38(9):1323-30. PubMed ID: 550668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Medicamentous strategy for improving the quality of life in the senescence].
    Knoll J
    Wien Med Wochenschr Suppl; 1986; 98():1-18. PubMed ID: 3097965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.